GlassScriptPhysician profile
Sara B Rubenacker
NPI 1023304094
$2,074.00
in general payments reported to CMS, 2019-2025
19 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $195 · 2021: $99.41 · 2022: $231 · 2023: $727 · 2024: $194 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $84.99 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.40 |
| Education | $84.99 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.74 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $276.66 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $246.01 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $235.66 | 2023-2025 | Veozah |
| Organon LLC | $216.13 | 2022-2025 | Nexplanon |
| Allergan, INC. | $207.35 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.24 | 2019-2022 | |
| Avion Pharmaceuticals | $61.54 | 2020-2022 | |
| Exeltis, USA INC. | $43.53 | 2022-2025 | Slynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.68 | 2020-2021 | |
| Sage Therapeutics, LLC | $27.24 | 2023 | |
| Dexcom, INC. | $26.77 | 2025 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Daiichi Sankyo INC. | $24.93 | 2021 | |
| Ethicon US, LLC | $23.04 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $22.50 | 2021 | |
| Amag Pharmaceuticals, INC. | $18.67 | 2019 | |
| Olympus America INC. | $12.47 | 2019 | |
| Therapeuticsmd, INC. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Rubenacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.